Meta-analysis of clinical efficacy and safety of yangxuenao granules combined with cholinesterase inhibitors in the treatment of vascular cognitive impairment

Minerva Med. 2023 Jun;114(3):399-401. doi: 10.23736/S0026-4806.22.08339-2. Epub 2022 Sep 30.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Alzheimer Disease*
  • Cholinesterase Inhibitors / therapeutic use
  • Cognitive Dysfunction*
  • Humans
  • Treatment Outcome

Substances

  • Cholinesterase Inhibitors